CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
The Clorox Company (NYSE:CLX ) Consumer Analyst Group of New York Conference (CAGNY) 2025 February 20, 2025 2:00 PM ET Company Participants Linda Rendle - Chair and Chief Executive Officer Kevin Jacobsen - Executive Vice President and Chief Financial Officer Luc Bellet - Treasurer and incoming Chief Financial Officer Conference Call Participants Unidentified Company Representative Good afternoon. Next up, it is my pleasure to welcome Clorox back to the CAGNY stage.
CLX faces near-term pressure from weak earnings and ongoing operational transitions, but its long-term strategy bodes well.
Shares of Clorox (CLX -0.43%) are down 7.4% since it reported earnings on Feb. 3. The consumer goods company continues to make big changes it hopes can chart a path toward margin expansion.
Now that the first quarter of 2025 is underway, investors across the board are probably looking to find the best ideas to get their portfolios started on the right foot. This way, they can have not only the momentum but also the liquidity necessary to chase the growth plays that will become available in later months.
Clorox Company CLX reported better-than-expected second-quarter financial results Monday after the bell.
CLX's Q2 results reflect strong core fundamentals, market share gains and gross margin expansion amid cyberattack recovery and divestitures.
The Clorox Company (NYSE:CLX ) Q2 2025 Earnings Conference Call February 3, 2025 5:00 PM ET Company Participants Lisah Burhan - Vice President, Investor Relations Linda Rendle - Chair and CEO Kevin Jacobsen - Chief Financial Officer Luc Bellet - Treasurer and Incoming CFO Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Filippo Falorni - Citi Anna Lizzul - Bank of America Kaumil Gajrawala - Jefferies Bonnie Herzog - Goldman Sachs Chris Carey - Wells Fargo Olivia Tong - Raymond James Andrea Teixeira - JP Morgan Robert Moskow - TD Cowen Kevin Grundy - BNP Paribas Linda Bolton Weiser - D.A. Davidson Javier Escalante - Evercore ISI Steve Powers - Deutsche Bank Lauren Lieberman - Barclays Operator Good day, ladies and gentlemen, and welcome to The Clorox Company Second Quarter Fiscal Year 2025 Earnings Release Conference Call.
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox (CLX) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $2.16 per share a year ago.
An almost immediate retraction of a 25% tariff on imported goods from Mexico prodded this relief trade.
Steven Cress talks to Kim Khan about his top dividend stocks for the year. Diversification and strong fundamentals are key strategies for investors.